ArticleJournal of translational medicine2024
Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease.
Halvard Bonig et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.